27 March 2026
A new £1.5 million research facility will be established at New Cross Hospital, delivering high-quality, cutting-edge research for the region.
The Royal Wolverhampton NHS Trust has been awarded £1.5 million from the National Institute for Health and Care Research (NIHR) through its Capital Investment Programme.
This significant investment will support an ambitious programme to refurbish and modernise dedicated clinical research facilities.
The newly funded refurbishment project will deliver:
Being a research-active trust brings substantial benefits for patients, staff, and the wider health system.
This investment reinforces the Trust’s commitment to evidence-based, patient-centred care, while contributing to national and global advances in health and medical research.
Pauline Boyle, Group Director of Research & Development, said: “Securing this NIHR capital investment is a major milestone for our organisation.
“These upgraded facilities will enable us to expand both the number and range of studies we deliver, giving more patients the opportunity to access innovative treatments and play an active role in shaping the future of healthcare.
“I am incredibly proud of our team and grateful to the NIHR for recognising the strength and ambition of our research programme.”
Brian McKaig, Chief Medical Officer at The Royal Wolverhampton NHS Trust, added: “Research is at the heart of high-quality, modern healthcare. This investment will ensure our clinicians and researchers have the environment they need to deliver world-class studies that directly benefit our patients.
“A strong research culture leads to better outcomes, improved experiences, and higher-quality services — and this funding will help us build on that foundation.”